Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetic effects of angiotensin-converting enzyme inhibitors over age-related urea and creatinine variations in patients with dementia due to Alzheimer disease.

Colombia medica (Cali, Colombia) - 30 Jun 2016

Ferreira de Oliveira Fabricio, Berretta Juliana Marília, Suchi Chen Elizabeth, Cardoso Smith Marilia, Ferreira Bertolucci Paulo Henrique

Abstract excerpt

BACKGROUND: Renal function declines according to age and vascular risk factors, whereas few data are available regarding genetically-mediated effects of anti-hypertensives over renal function. OBJECTIVE: To estimate urea and creatinine variations in dementia due to Alzheimer disease (AD) by way of a pharmacogenetic analysis of the anti-hypertensive effects of angiotensin-converting enzyme inhibitors (ACEis)....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Angiotensin-Converting Enzyme Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Pressure

Share to Creatinine

Share to Fasting

Share to Hypertension

Share to Peptidyl-Dipeptidase A

Source

Open in PubMed Open full text

Identifiers

PMID: 27546928
PMCID: PMC4975126

Genes

ACE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetic effects of angiotensin-converting enzyme inhibitors over age-related urea and creatinine variations in patients with dementia due to Alzheimer disease.PMID 27546928Read ↗

Pharmacogenetic analyses of variations of measures of cardiovascular risk in Alzheimer's dementia.Semantic proximity Read ↗

Renal function and risk of dementia: a Mendelian randomization study.Semantic proximity Read ↗

Pharmacogenetics of Angiotensin-Converting Enzyme Inhibitors in Patients with Alzheimer's Disease Dementia.Semantic proximity Read ↗

Angiotensin-converting enzyme inhibition and Alzheimer’s disease: Findings from proteome-wide Mendelian randomization and a large prospective cohort studySemantic proximity Read ↗

Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer’s disease: a Mendelian randomization studySemantic proximity Read ↗

Pharmacogenetics of angiotensin modulators according to APOE-ϵ4 alleles and the ACE insertion/deletion polymorphism in Alzheimer's disease.Semantic proximity Read ↗

Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer's disease: a Mendelian randomization study.Semantic proximity Read ↗

Class-Specific Antihypertensives and Alzheimer's Disease: Genotype- and Hypertension-Stratified Analysis.Semantic proximity Read ↗

Brain-penetrating angiotensin-converting enzyme inhibitors and cognitive change in patients with dementia due to Alzheimer's disease.Semantic proximity Read ↗

Association of antihypertensive drug target genes with alzheimer's disease: a mendelian randomization study.Semantic proximity Read ↗

ACE inhibition increases Alzheimer’s disease risk by promoting tau phosphorylationSemantic proximity Read ↗

Repurposing antihypertensive drugs for the prevention of Alzheimer’s disease: a Mendelian Randomization studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.